Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1969;40:653-659

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LOEB, H. S.
Right arrow Articles by GUNNAR, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LOEB, H. S.
Right arrow Articles by GUNNAR, R. M.

(Circulation. 1969;40:653.)
© 1969 American Heart Association, Inc.


Hypovolemia in Shock Due to Acute Myocardial Infarction

HENRY S. LOEB M.D.1; RAYMOND J. PIETRAS M.D.1; JOHN R. TOBIN JR. M.D.1; ROLF M. GUNNAR M.D.1

1 From the Department of Adult Cardiology and the Hektoen Institute for Medical Research of the Cook County Hospital; the Section of Cardiology, Department of Medicine, University of Illinois College of Medicine, Chicago, Illinois; and the Department of Medicine of the Loyola University Stritch School of Medicine, Hines, Illinois.

Twelve patients with the clinical features of shock following acute myocardial infarction were treated with low molecular weight dextran (LMWD) as a plasma volume expander. Two of the patients had elevated central venous pressures (CVP), and neither responded favorably to plasma volume expansion. The remaining 10 patients had CVPs under 7 mm Hg prior to dextran infusion; five survived. Each survivor responded favorably to dextran infusion manifested by an increase in arterial pressure and cardiac index. The average increase in CVP in these patients was 1.0 mm Hg per 100 ml of dextran infused. The other five patients died either without recovering from shock or in chronic cardiac failure. These patients failed to show a significant increase in arterial pressure or cardiac index after dextran infusion; CVP increased by an average of 1.9 mm Hg per 100 ml infused. Hypovolemia must be considered in all patients in whom clinical evidence of shock develops as a complication of acute myocardial infarction, and if the CVP is normal or low, plasma volume expansion should be undertaken with caution. Increase in arterial pressure and evidence of improved cardiac index with little rise in CVP indicate a good response to the infusion and excellent prognosis for survival.


Key Words: Central venous pressure • Dextran • Pulmonary arterial pressure • Cardiac index